| Year |
Citation |
Score |
| 2024 |
Westerman KE, Kilpeläinen TO, Sevilla-Gonzalez M, Connelly MA, Wood AC, Tsai MY, Taylor KD, Rich SS, Rotter JI, Otvos JD, Bentley AR, Mora S, Aschard H, Rao DC, Gu C, et al. Refinement of a published gene-physical activity interaction impacting HDL-cholesterol: role of sex and lipoprotein subfractions. Medrxiv : the Preprint Server For Health Sciences. PMID 38313294 DOI: 10.1101/2024.01.23.24301689 |
0.305 |
|
| 2022 |
Mietus-Snyder M, Suslovic W, Delaney M, Playford MP, Ballout RA, Barber JR, Otvos JD, DeBiasi RL, Mehta NN, Remaley AT. Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity. Frontiers in Cardiovascular Medicine. 9: 1033660. PMID 36312284 DOI: 10.3389/fcvm.2022.1033660 |
0.343 |
|
| 2022 |
Chevli PA, Islam T, Pokharel Y, Rodriguez F, Virani SS, Blaha MJ, Bertoni AG, Budoff M, Otvos JD, Shapiro MD. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of Clinical Lipidology. PMID 36180367 DOI: 10.1016/j.jacl.2022.09.005 |
0.328 |
|
| 2021 |
Ballout RA, Kong H, Sampson M, Otvos JD, Cox AL, Agbor-Enoh S, Remaley AT. The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19. Biomedicines. 9. PMID 34572275 DOI: 10.3390/biomedicines9091090 |
0.378 |
|
| 2020 |
Garcia E, Bennett DW, Connelly MA, Jeyarajah EJ, Warf FC, Shalaurova I, Matyus SP, Wolak-Dinsmore J, Oskardmay DN, Young RM, Sampson M, Remaley AT, Otvos JD. The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B. Lipids in Health and Disease. 19: 247. PMID 33261644 DOI: 10.1186/s12944-020-01424-2 |
0.366 |
|
| 2020 |
Bedi S, Garcia E, Jeyarajah EJ, Shalaurova I, Perez-Matos MC, Jiang ZG, Dullaart RPF, Matyus SP, Kirk WJ, Otvos JD, Davidson WS, Connelly MA. Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay. Journal of Clinical Medicine. 9. PMID 32927635 DOI: 10.3390/Jcm9092915 |
0.354 |
|
| 2020 |
Flores-Guerrero JL, Gruppen EG, Connelly MA, Shalaurova I, Otvos JD, Garcia E, Bakker SJL, Dullaart RPF. A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort. Journal of Clinical Medicine. 9: 2781. PMID 32867285 DOI: 10.3390/Jcm9092781 |
0.402 |
|
| 2020 |
Singh K, Chandra A, Sperry T, Joshi PH, Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen EG, Connelly MA, Ayers CR, Rohatgi A. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis. Circulation. 142: 657-669. PMID 32804568 DOI: 10.1161/Circulationaha.120.045713 |
0.462 |
|
| 2020 |
Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, Sethi A, Fleming JK, Otvos JD, Meeusen JW, Delaney SR, Jaffe AS, Shamburek R, Amar M, Remaley AT. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. Jama Cardiology. PMID 32101259 DOI: 10.1001/Jamacardio.2020.0013 |
0.426 |
|
| 2020 |
Remaley AT, Otvos JD. Methodological issues regarding: "A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals". Atherosclerosis. 302: 55-56. PMID 32029245 DOI: 10.1016/J.Atherosclerosis.2020.01.020 |
0.411 |
|
| 2020 |
Garcia E, Shalaurova I, Matyus SP, Oskardmay DN, Otvos JD, Dullaart RPF, Connelly MA. Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance Index. Journal of Clinical Medicine. 9. PMID 31979327 DOI: 10.3390/Jcm9020321 |
0.32 |
|
| 2020 |
Katz LE, Otvos JD, Drews K, Tesfaldet B, Bacha F, Willi SM, Marcovina SM, Mckay S, Weinstock RS. 59-OR: Lipoprotein Particle Distribution by NMR in Youth with Type 2 Diabetes (T2D) in the TODAY Study Diabetes. 69. DOI: 10.2337/Db20-59-Or |
0.367 |
|
| 2020 |
Flores-Guerrero JL, Connelly MA, Shalaurova IY, Gruppen EG, Otvos JD, Dullaart RPF, Bakker SJI. 1437-P: A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched-Chain Amino Acids, Is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort Diabetes. 69. DOI: 10.2337/Db20-1437-P |
0.313 |
|
| 2020 |
Chung ST, Matta S, Meyers A, Cravalho CK, Villalobos-Perez A, Mabundo L, Courville AB, Sampson ML, Otvos JD, Magge SN. 1243-P: NMR-Derived Biomarkers Identify Cardiometabolic Disease Risk in Youth Diabetes. 69. DOI: 10.2337/Db20-1243-P |
0.306 |
|
| 2019 |
Lamprea-Montealegre JA, McClelland RL, Otvos JD, Mora S, Koch M, Jensen MK, de Boer IH. Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 8: e013713. PMID 31818211 DOI: 10.1161/Jaha.119.013713 |
0.427 |
|
| 2019 |
Garcia E, Osté MCJ, Bennett DW, Jeyarajah EJ, Shalaurova I, Gruppen EG, Hazen SL, Otvos JD, Bakker SJL, Dullaart RPF, Connelly MA. High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. Journal of Clinical Medicine. 8. PMID 31683780 DOI: 10.3390/Jcm8111813 |
0.352 |
|
| 2019 |
Fashanu OE, Oyenuga AO, Zhao D, Tibuakuu M, Mora S, Otvos JD, Stein JH, Michos ED. GlycA, a Novel Inflammatory Marker and Its Association With Peripheral Arterial Disease and Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis. Angiology. 3319719845185. PMID 31030528 DOI: 10.1177/0003319719845185 |
0.329 |
|
| 2019 |
Schutten JC, Gomes-Neto AW, Navis G, Gansevoort RT, Dullaart RPF, Kootstra-Ros JE, Danel RM, Goorman F, Gans ROB, de Borst MH, Jeyarajah EJ, Shalaurova I, Otvos JD, Connelly MA, Bakker SJL. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study. Journal of Clinical Medicine. 8. PMID 30717286 DOI: 10.3390/Jcm8020169 |
0.364 |
|
| 2019 |
Ezeigwe A, Fashanu OE, Zhao D, Budoff MJ, Otvos JD, Thomas IC, Mora S, Tibuakuu M, Michos ED. The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 282: 91-99. PMID 30716566 DOI: 10.1016/J.Atherosclerosis.2019.01.011 |
0.317 |
|
| 2018 |
Flores-Guerrero JL, Osté MCJ, Kieneker LM, Gruppen EG, Wolak-Dinsmore J, Otvos JD, Connelly MA, Bakker SJL, Dullaart RPF. Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort Study. Journal of Clinical Medicine. 7: 513. PMID 30518023 DOI: 10.3390/Jcm7120513 |
0.348 |
|
| 2018 |
Benson EA, Tibuakuu M, Zhao D, Akinkuolie AO, Otvos JD, Duprez DA, Jacobs DR, Mora S, Michos ED. Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis. Clinical Cardiology. PMID 30452775 DOI: 10.1002/Clc.23069 |
0.339 |
|
| 2018 |
Delatour V, Clouet-Foraison N, Gaie-Levrel F, Marcovina SM, Hoofnagle AN, Kuklenyik Z, Caulfield MP, Otvos JD, Krauss RM, Kulkarni KR, Contois JH, Remaley AT, Vesper HW, Cobbaert CM, Gillery P. Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization. Clinical Chemistry. PMID 30087138 DOI: 10.1373/Clinchem.2018.288746 |
0.42 |
|
| 2018 |
Muhlestein JB, May HT, Galenko O, Knowlton KU, Otvos JD, Connelly MA, Lappe DL, Anderson JL. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study. American Heart Journal. 202: 27-32. PMID 29803983 DOI: 10.1016/J.Ahj.2018.04.003 |
0.327 |
|
| 2018 |
Wolak-Dinsmore J, Gruppen EG, Shalaurova I, Matyus SP, Grant RP, Gegen R, Bakker SJL, Otvos JD, Connelly MA, Dullaart RPF. A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness. Clinical Biochemistry. PMID 29432757 DOI: 10.1016/J.Clinbiochem.2018.02.001 |
0.334 |
|
| 2018 |
Otvos JD, Guyton JR, Connelly MA, Akapame S, Bittner V, Kopecky SL, Lacy M, Marcovina SM, Muhlestein JB, Boden WE. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial. Journal of Clinical Lipidology. 12: 348. PMID 29409728 DOI: 10.1016/J.Jacl.2018.01.002 |
0.493 |
|
| 2017 |
Weiss R, Nassar H, Sinnreich R, Ahmad WA, Otvos J, Kark JD. Palestinian Arab ethnicity is associated with an adverse metabolic phenotype. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 28987777 DOI: 10.1016/J.Cca.2017.10.004 |
0.43 |
|
| 2017 |
Davidson WS, Heink A, Sexmith H, Dolan LM, Gordon SM, Otvos JD, Melchior JT, Elder DA, Khoury J, Geh E, Shah AS. Obesity is Associated with an Altered HDL Subspecies Profile Among Adolescents with Metabolic Disease. Journal of Lipid Research. PMID 28743729 DOI: 10.1194/Jlr.M078667 |
0.326 |
|
| 2017 |
Garcia E, Wolak-Dinsmore J, Wang Z, Li XS, Bennett DW, Connelly MA, Otvos JD, Hazen SL, Jeyarajah EJ. NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting. Clinical Biochemistry. PMID 28624482 DOI: 10.1016/J.Clinbiochem.2017.06.003 |
0.36 |
|
| 2017 |
Orchard TJ, Cariou B, Connelly MA, Otvos JD, Zhang S, Antalis CJ, Ivanyi T, Hoogwerf BJ. The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes. Cardiovascular Diabetology. 16: 73. PMID 28587667 DOI: 10.1186/S12933-017-0555-1 |
0.33 |
|
| 2017 |
AbouAssi H, Connelly MA, Bateman LA, Tune KN, Huebner JL, Kraus VB, Winegar DA, Otvos JD, Kraus WE, Huffman KM. Does a lack of physical activity explain the rheumatoid arthritis lipid profile? Lipids in Health and Disease. 16: 39. PMID 28187765 DOI: 10.1186/S12944-017-0427-4 |
0.457 |
|
| 2017 |
Gomaraschi M, Kempen H, Simonelli S, Calabresi L, Moerland M, Otvos J, Jeyarajah E, Kallend D, Wijngaard P. Effects of a single infusion of synthetic HDL containing apoA-IMilano (MDCO-216) in healthy volunteers and stable coronary artery disease patients Nutrition Metabolism and Cardiovascular Diseases. 27. DOI: 10.1016/J.Numecd.2016.11.066 |
0.329 |
|
| 2016 |
Kempen HJ, Gomaraschi M, Simonelli S, Calabresi L, Moerland M, Otvos J, Jeyarajah E, Kallend D, Wijngaard PLJ. Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients Atherosclerosis. 255: 17-24. PMID 27816804 DOI: 10.1016/J.Atherosclerosis.2016.10.042 |
0.411 |
|
| 2016 |
May HT, Anderson JL, Winegar DA, Rollo J, Connelly MA, Otvos JD, Muhlestein JB. Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography. Clinical Biochemistry. PMID 27616009 DOI: 10.1016/J.Clinbiochem.2016.09.004 |
0.472 |
|
| 2016 |
Connelly MA, Shimizu C, Winegar DA, Shalaurova I, Pourfarzib R, Otvos JD, Kanegaye JT, Tremoulet AH, Burns JC. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children. Bmc Pediatrics. 16: 151. PMID 27596163 DOI: 10.1186/S12887-016-0688-5 |
0.36 |
|
| 2016 |
Ditah C, Otvos J, Nassar H, Shaham D, Sinnreich R, Kark JD. Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample. Atherosclerosis. 251: 124-131. PMID 27318832 DOI: 10.1016/J.Atherosclerosis.2016.06.010 |
0.493 |
|
| 2016 |
Connelly MA, Gruppen EG, Otvos JD, Dullaart RP. Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry. 459: 177-186. PMID 27312321 DOI: 10.1016/J.Cca.2016.06.012 |
0.315 |
|
| 2016 |
Gruppen EG, Connelly MA, Vart P, Otvos JD, Bakker SJ, Dullaart RP. GlycA, a novel proinflammatory glycoprotein biomarker, and high-sensitivity C-reactive protein are inversely associated with sodium intake after controlling for adiposity: the Prevention of Renal and Vascular End-Stage Disease study. The American Journal of Clinical Nutrition. PMID 27305953 DOI: 10.3945/Ajcn.116.133744 |
0.339 |
|
| 2016 |
Kim DS, Li YK, Bell GA, Burt AA, Vaisar T, Hutchins PM, Furlong CE, Otvos JD, Polak JF, Arnan MK, Kaufman JD, McClelland RL, Longstreth WT, Jarvik GP. Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA). Journal of the American Heart Association. 5. PMID 27207961 DOI: 10.1161/Jaha.115.002977 |
0.507 |
|
| 2016 |
Tehrani DM, Zhao Y, Blaha MJ, Mora S, Mackey RH, Michos ED, Budoff MJ, Cromwell W, Otvos JD, Rosenblit PD, Wong ND. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]). The American Journal of Cardiology. PMID 27156827 DOI: 10.1016/J.Amjcard.2016.03.040 |
0.5 |
|
| 2016 |
Kempen HJ, Asztalos BF, Moerland M, Jeyarajah E, Otvos J, Kallend DG, Bellibas SE, Wijngaard PLJ. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients Arteriosclerosis, Thrombosis, and Vascular Biology. 36: 736-742. PMID 26916733 DOI: 10.1161/Atvbaha.115.307052 |
0.409 |
|
| 2016 |
Connelly MA, Shalaurova I, Otvos JD. High-density lipoprotein and inflammation in cardiovascular disease. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 26850902 DOI: 10.1016/J.Trsl.2016.01.006 |
0.471 |
|
| 2016 |
Durcan L, Winegar DA, Connelly MA, Otvos JD, Magder LS, Petri M. Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy. The Journal of Rheumatology. PMID 26834214 DOI: 10.3899/Jrheum.150437 |
0.414 |
|
| 2016 |
Jiang ZG, Tapper EB, Connelly MA, Pimentel CM, Feldbrügge L, Kim M, Krawczyk S, Afdh Al N, Robson SC, Herman M, Otvos JD, Mukamal KJ, Lai M. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26815314 DOI: 10.1111/Liv.13076 |
0.39 |
|
| 2016 |
Durcan L, Arbab-Zadeh A, Connelly M, Otvos J, Magder LS, Petri M. THU0339 Non-Calcified Coronary Artery Plaque Associates with Adverse Lipoprotein Profiles in Systemic Lupus Erythematosus Annals of the Rheumatic Diseases. 75: 309-310. DOI: 10.1136/Annrheumdis-2016-Eular.3708 |
0.444 |
|
| 2015 |
Gruppen EG, Riphagen IJ, Connelly MA, Otvos JD, Bakker SJ, Dullaart RP. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function. Plos One. 10: e0139057. PMID 26398105 DOI: 10.1371/Journal.Pone.0139057 |
0.336 |
|
| 2015 |
Duprez DA, Otvos J, Tracy RP, Feingold KR, Greenland P, Gross MD, Lima JA, Mackey RH, Neaton JD, Sanchez OA, Jacobs DR. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 4: e002295. PMID 26370448 DOI: 10.1161/Jaha.115.002295 |
0.448 |
|
| 2015 |
Gruppen EG, Connelly MA, Otvos JD, Bakker SJ, Dullaart RP. A novel protein glycan biomarker and LCAT activity in metabolic syndrome. European Journal of Clinical Investigation. 45: 850-9. PMID 26081900 DOI: 10.1111/Eci.12481 |
0.421 |
|
| 2015 |
Ballantyne CM, Braeckman RA, Bays HE, Kastelein JJ, Otvos JD, Stirtan WG, Doyle RT, Soni PN, Juliano RA. Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study). Journal of Clinical Lipidology. 9: 377-83. PMID 26073397 DOI: 10.1016/J.Jacl.2014.11.009 |
0.412 |
|
| 2015 |
Dullaart RP, Gruppen EG, Connelly MA, Otvos JD, Lefrandt JD. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status. Clinical Biochemistry. 48: 811-4. PMID 25977069 DOI: 10.1016/J.Clinbiochem.2015.05.001 |
0.319 |
|
| 2015 |
Ormseth MJ, Chung CP, Oeser AM, Connelly MA, Sokka T, Raggi P, Solus JF, Otvos JD, Stein CM. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. Arthritis Research & Therapy. 17: 117. PMID 25956924 DOI: 10.1186/S13075-015-0646-X |
0.334 |
|
| 2015 |
Sanchez OA, Duprez DA, Daniels LB, Maisel AS, Otvos JD, Peralta CA, Lima JA, Bahrami H, Jacobs DR. The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis. Metabolism: Clinical and Experimental. 64: 857-61. PMID 25931335 DOI: 10.1016/J.Metabol.2015.04.001 |
0.331 |
|
| 2015 |
Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, Tracy RP. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. Clinical Chemistry. 61: 714-23. PMID 25779987 DOI: 10.1373/Clinchem.2014.232918 |
0.329 |
|
| 2015 |
Rashid S, Sniderman A, Melone M, Brown PE, Otvos JD, Mente A, Schulze K, McQueen MJ, Anand SS, Yusuf S. Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians. European Journal of Preventive Cardiology. 22: 468-77. PMID 24659026 DOI: 10.1177/2047487314528461 |
0.343 |
|
| 2015 |
Ormseth M, Chung C, Oeser A, Connelly M, Sokka T, Raggi P, Solus J, Otvos J, Stein CM. FRI0089 Utility of a Novel Inflammatory Marker, Glyca, for Assessment of Rheumatoid Arthritis Disease Activity and Coronary Atherosclerosis Annals of the Rheumatic Diseases. 74: 452-452. DOI: 10.1136/Annrheumdis-2015-Eular.6003 |
0.316 |
|
| 2015 |
Durcan LJ, Winegar D, Connelly MA, Otvos J, Magder L, Petri M. FRI0406 Small LDL-P Increases with Increased Disease Activity in SLE Annals of the Rheumatic Diseases. 74: 573-573. DOI: 10.1136/Annrheumdis-2015-Eular.4310 |
0.459 |
|
| 2015 |
Chung C, Ormseth M, Connelly M, Oeser A, Solus J, Otvos J, Raggi P, Stein C. FRI0391 GLYCA, A Novel Marker of Inflammation, Is Elevated in Systemic Lupus Erythematosus Annals of the Rheumatic Diseases. 74: 568.3-568. DOI: 10.1136/Annrheumdis-2015-Eular.1912 |
0.361 |
|
| 2014 |
Kempen HJ, Schranz DB, Asztalos BF, Otvos J, Jeyarajah E, Drazul-Schrader D, Collins HL, Adelman SJ, Wijngaard PL. Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size. Journal of Lipids. 2014: 923903. PMID 25478232 DOI: 10.1155/2014/923903 |
0.447 |
|
| 2014 |
Shalaurova I, Connelly MA, Garvey WT, Otvos JD. Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metabolic Syndrome and Related Disorders. 12: 422-9. PMID 24959989 DOI: 10.1089/Met.2014.0050 |
0.383 |
|
| 2014 |
Dullaart RPF, Otvos JD, James RW. Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects Clinical Biochemistry. 47: 1022-1027. PMID 24769273 DOI: 10.1016/j.clinbiochem.2014.04.013 |
0.351 |
|
| 2014 |
Williams PT, Zhao XQ, Marcovina SM, Otvos JD, Brown BG, Krauss RM. Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease. Atherosclerosis. 233: 713-20. PMID 24603218 DOI: 10.1016/J.Atherosclerosis.2014.01.034 |
0.442 |
|
| 2014 |
Jago R, Drews KL, Otvos JD, Foster GD, Marcus MD, Buse JB, Mietus-Snyder M, Willi SM. Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents. The Journal of Pediatrics. 164: 1091-1098.e3. PMID 24508445 DOI: 10.1016/J.Jpeds.2013.12.029 |
0.347 |
|
| 2014 |
Folse H, Goswami D, Rengarajan B, Kahn R, Budoff M, Winegar D, Otvos J. Using Low-Density Lipoprotein (LDL) Particle Number (LDL-P) versus LDL Cholesterol (LDL-C) to Guide Preventative Therapy for Cardiovascular Disease Journal of Clinical Lipidology. 8: 297-298. DOI: 10.1016/J.Jacl.2014.02.016 |
0.487 |
|
| 2014 |
Banach M, Rysz J, Rizzo M, Otvos J, Toth P, Pencina M, Mlynarski W, Mikhailidis D. Investigating dysfunctional-hdl in selected groups of patients at high risk of cardiovascular events (dys-hdl study) - Protocol and organization Atherosclerosis. 235: e171-e172. DOI: 10.1016/J.Atherosclerosis.2014.05.496 |
0.358 |
|
| 2014 |
Kempen H, Schranz D, Asztalos B, Otvos J, Jeyarajah E, Drazul-Schrader D, Collins H, Adelman S. Incubation of MDCO216 with human serum potentiates ABCA1 mediated cholesterol efflux capacity and generates new prebeta-1 Hdl Atherosclerosis. 235: e45-e46. DOI: 10.1016/J.Atherosclerosis.2014.05.103 |
0.388 |
|
| 2013 |
Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the diabetes prevention program Journal of Clinical Endocrinology and Metabolism. 98: 3989-3998. PMID 23979954 DOI: 10.1210/Jc.2013-1452 |
0.326 |
|
| 2013 |
Kramer MS, Kahn SR, Dahhou M, Otvos J, Genest J, Platt RW, Evans RW. Maternal lipids and small for gestational age birth at term. The Journal of Pediatrics. 163: 983-8. PMID 23810722 DOI: 10.1016/J.Jpeds.2013.05.014 |
0.402 |
|
| 2013 |
Mietus-Snyder M, Drews KL, Otvos JD, Willi SM, Foster GD, Jago R, Buse JB. Low-density lipoprotein cholesterol versus particle number in middle school children. The Journal of Pediatrics. 163: 355-62. PMID 23415622 DOI: 10.1016/J.Jpeds.2013.01.012 |
0.474 |
|
| 2013 |
Kwiterovich PO, Virgil DG, Chu AY, Khouzami VA, Alaupovic P, Otvos JD. Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2-3 months of age and their parents. Journal of Clinical Lipidology. 7: 29-37. PMID 23351580 DOI: 10.1016/J.Jacl.2012.09.002 |
0.34 |
|
| 2013 |
Ballantyne CM, Braeckman R, Bays H, Kastelein J, Otvos J, Stirtan W, Soni P. Effects of Icosapent Ethyl on Lipoprotein Particle Concentration and the Fatty Acid Desaturation Index in Statin-treated Patients With Persistent High Triglycerides (the ANCHOR Study) Journal of Clinical Lipidology. 7: 270-271. DOI: 10.1016/J.Jacl.2013.03.071 |
0.397 |
|
| 2012 |
Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). Journal of Clinical Lipidology. 6: 565-72. PMID 23312052 DOI: 10.1016/J.Jacl.2012.07.001 |
0.43 |
|
| 2012 |
Parish S, Offer A, Clarke R, Hopewell JC, Hill MR, Otvos JD, Armitage J, Collins R. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation. 125: 2469-78. PMID 22539783 DOI: 10.1161/CIRCULATIONAHA.111.073684 |
0.378 |
|
| 2011 |
Otvos JD. The surprising AIM-HIGH results are not surprising when viewed through a particle lens. Journal of Clinical Lipidology. 5: 368-70. PMID 21981836 DOI: 10.1016/J.Jacl.2011.06.012 |
0.311 |
|
| 2011 |
Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 3805-10. PMID 21931123 DOI: 10.1093/Ndt/Gfr542 |
0.425 |
|
| 2011 |
Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 219: 596-602. PMID 21868017 DOI: 10.1016/J.Atherosclerosis.2011.08.001 |
0.491 |
|
| 2011 |
Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy R, Neaton JD. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. Aids (London, England). 25: 2133-42. PMID 21857489 DOI: 10.1097/Qad.0B013E32834Be088 |
0.431 |
|
| 2011 |
Paynter NP, Sesso HD, Conen D, Otvos JD, Mora S. Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clinical Chemistry. 57: 1178-87. PMID 21700954 DOI: 10.1373/Clinchem.2011.167544 |
0.428 |
|
| 2011 |
Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. Journal of Clinical Lipidology. 5: 105-13. PMID 21392724 DOI: 10.1016/J.Jacl.2011.02.001 |
0.372 |
|
| 2011 |
Rosenson RS, Brewer HB, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clinical Chemistry. 57: 392-410. PMID 21266551 DOI: 10.1373/Clinchem.2010.155333 |
0.454 |
|
| 2011 |
Weiss R, Otvos JD, Sinnreich R, Miserez AR, Kark JD. The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. The Journal of Pediatrics. 158: 44-50. PMID 20801459 DOI: 10.1016/J.Jpeds.2010.07.002 |
0.445 |
|
| 2011 |
Duprez DA, Zhu N, Jacobs DR, Bahrami H, Lima J, Otvos J, Daniels LB, Maisel A. Incremental Predictive Value For Incident Cardiovascular Disease Of 4 Subclinical Markers Combined: Lipoprotein Particle Concentration, Nt-Probnp Concentration, Coronary Artery Calcification Score And Small Artery Stiffness In Asymptomatic Subjects In The Multi-Ethnic Study Of Atherosclerosis Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)61228-X |
0.368 |
|
| 2010 |
Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton NI, Friis-Møller N, Neuhaus J, Liappis AP, Phillips AN. Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 54: 275-84. PMID 20658749 DOI: 10.1097/Qai.0B013E3181D32158 |
0.474 |
|
| 2010 |
Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 59: 1153-60. PMID 20185808 DOI: 10.2337/Db09-1114 |
0.433 |
|
| 2010 |
Mora S, Otvos J, Ridker P. W26 Discordance Between Ldl Cholesterol And Ldl Particle Concentration In Relation To Incident Cvd Events In 27673 Women Atherosclerosis Supplements. 11: 6. DOI: 10.1016/S1567-5688(10)70027-1 |
0.446 |
|
| 2010 |
Virani SS, Catellier DJ, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM. DISCORDANCE BETWEEN TRADITIONAL LIPID PARAMETERS, APOLIPOPROTEINS AND LIPOPROTEIN PARTICLE NUMBER: INSIGHTS FROM THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) CAROTID MRI STUDY Journal of the American College of Cardiology. 55: A53.E501. DOI: 10.1016/S0735-1097(10)60502-5 |
0.419 |
|
| 2010 |
Orchard TJ, Robertson D, Bertolet M, Otvos J, Donner T, Ooi T, Pambianco G, Rana J, Smith D, Zoiopoulos L. INSULIN SENSITIZING THERAPY COMPARED TO INSULIN PROVIDING THERAPY FOR TYPE 2 DIABETES MELLITUS: EFFECTS ON LOW DENSITY LIPOPROTEIN PARTICLE CHARACTERISTICS BY NUCLEAR MAGNETIC RESONANCE LIPOPROFILE-III Journal of the American College of Cardiology. 55: A49.E462. DOI: 10.1016/S0735-1097(10)60463-9 |
0.36 |
|
| 2009 |
Howard WJ, Russell M, Fleg JL, Mete M, Ali T, Devereux RB, Galloway JM, Otvos JD, Ratner RE, Roman MJ, Silverman A, Umans JG, Weissman NJ, Wilson C, Howard BV. PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. Journal of Clinical Lipidology. 3: 322-331. PMID 20161568 DOI: 10.1016/J.Jacl.2009.09.001 |
0.462 |
|
| 2009 |
Masulli M, Patti L, Riccardi G, Vaccaro O, Annuzzi G, Ebbesson SO, Fabsitz RR, Howard WJ, Otvos JD, Roman MJ, Wang H, Weissman NJ, Howard BV, Rivellese AA. Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study). The American Journal of Cardiology. 104: 1516-21. PMID 19932785 DOI: 10.1016/J.Amjcard.2009.07.021 |
0.512 |
|
| 2009 |
Duprez DA, Kuller LH, Tracy R, Otvos J, Cooper DA, Hoy J, Neuhaus J, Paton NI, Friis-Moller N, Lampe F, Liappis AP, Neaton JD. Lipoprotein particle subclasses, cardiovascular disease and HIV infection. Atherosclerosis. 207: 524-9. PMID 19515371 DOI: 10.1016/J.Atherosclerosis.2009.05.001 |
0.328 |
|
| 2009 |
Weiss R, Otvos JD, Flyvbjerg A, Miserez AR, Frystyk J, Sinnreich R, Kark JD. Adiponectin and lipoprotein particle size. Diabetes Care. 32: 1317-9. PMID 19389813 DOI: 10.2337/Dc09-0084 |
0.421 |
|
| 2009 |
Rosenson RS, Otvos JD, Hsia J. Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study. Diabetes Care. 32: 1087-91. PMID 19265025 DOI: 10.2337/Dc08-1681 |
0.458 |
|
| 2009 |
Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 119: 931-9. PMID 19204302 DOI: 10.1161/Circulationaha.108.816181 |
0.456 |
|
| 2009 |
El Harchaoui K, Arsenault BJ, Franssen R, Després JP, Hovingh GK, Stroes ES, Otvos JD, Wareham NJ, Kastelein JJ, Khaw KT, Boekholdt SM. High-density lipoprotein particle size and concentration and coronary risk. Annals of Internal Medicine. 150: 84-93. PMID 19153411 DOI: 10.7326/0003-4819-150-2-200901200-00006 |
0.467 |
|
| 2009 |
Mora S, Buring JE, Ridker PM, Rifai N, Otvos JD, Rosenson RS. Response to Letter Regarding Article, “Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women” Circulation. 120. DOI: 10.1161/Circulationaha.109.881219 |
0.436 |
|
| 2009 |
Kwiterovich P, Virgil D, Khouzami V, Otvos J. Abstract: P357 QUANTITATIVE EXPRESSION OF THE LARGEST SUBCLASS OF HDL (H5C), VLDLTG AND SMALL LDL PARTICLES (SLDLP) IN INFANTS AND THEIR PARENTS Atherosclerosis Supplements. 10. DOI: 10.1016/S1567-5688(09)70652-X |
0.349 |
|
| 2008 |
Otvos JD, Rudel LL, McConnell JP. Concerns regarding lipoprotein particle measurement by ion mobility analysis. Clinical Chemistry. 54: 2086-7; author reply. PMID 19042998 DOI: 10.1373/Clinchem.2008.113795 |
0.451 |
|
| 2008 |
Hsia J, Otvos JD, Rossouw JE, Wu L, Wassertheil-Smoller S, Hendrix SL, Robinson JG, Lund B, Kuller LH. Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1666-71. PMID 18599797 DOI: 10.1161/Atvbaha.108.170431 |
0.448 |
|
| 2008 |
van der Graaf A, Rodenburg J, Vissers MN, Hutten BA, Wiegman A, Trip MD, Stroes ES, Wijburg FA, Otvos JD, Kastelein JJ. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia. The Journal of Pediatrics. 152: 873-8. PMID 18492534 DOI: 10.1016/J.Jpeds.2007.11.043 |
0.339 |
|
| 2007 |
Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, Wilson PW, D'Agostino RB. LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. Journal of Clinical Lipidology. 1: 583-92. PMID 19657464 DOI: 10.1016/J.Jacl.2007.10.001 |
0.509 |
|
| 2007 |
Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation. 116: 2029-35. PMID 17923573 DOI: 10.1161/Circulationaha.107.704031 |
0.372 |
|
| 2007 |
El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. Journal of the American College of Cardiology. 49: 547-53. PMID 17276177 DOI: 10.1016/J.Jacc.2006.09.043 |
0.495 |
|
| 2007 |
Singh U, Otvos J, Dasgupta A, Lemos JAd, Devaraj S, Jialal I. High-dose α-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy Clinical Chemistry. 53: 525-528. PMID 17234730 DOI: 10.1373/Clinchem.2006.078865 |
0.438 |
|
| 2007 |
Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC, O'Leary DH, Saad MF, Tsai MY, Sharrett AR. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 192: 211-7. PMID 16765964 DOI: 10.1016/J.Atherosclerosis.2006.05.007 |
0.461 |
|
| 2007 |
Steeg WAvd, Holme I, Boekholdt SM, Otvos JD, Stroes ES, Wareham NJ, Kastelein JJ, Khaw KT. Lb-Or-3 Relationship Between High-Density Lipoprotein Particle Size And Coronary Artery Disease Risk In The Epic-Norfolk Prospective Study Atherosclerosis Supplements. 8: 227. DOI: 10.1016/S1567-5688(07)71862-7 |
0.417 |
|
| 2006 |
Cromwell WC, Otvos JD. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl. The American Journal of Cardiology. 98: 1599-602. PMID 17145217 DOI: 10.1016/J.Amjcard.2006.07.036 |
0.469 |
|
| 2006 |
Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clinics in Laboratory Medicine. 26: 847-70. PMID 17110242 DOI: 10.1016/J.Cll.2006.07.006 |
0.502 |
|
| 2006 |
Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabetic Medicine : a Journal of the British Diabetic Association. 23: 955-66. PMID 16922701 DOI: 10.1111/J.1464-5491.2006.01905.X |
0.374 |
|
| 2006 |
Seip RL, Otvos J, Bilbie C, Tsongalis GJ, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos TJ, Pescatello L, Moyna N, Thompson PD. The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise. Atherosclerosis. 188: 126-33. PMID 16842800 DOI: 10.1016/J.Atherosclerosis.2005.06.050 |
0.361 |
|
| 2006 |
Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation. 113: 1556-63. PMID 16534013 DOI: 10.1161/Circulationaha.105.565135 |
0.461 |
|
| 2006 |
Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PW, D'Agostino RB, Vasan RS, Robins SJ. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 113: 20-9. PMID 16380547 DOI: 10.1161/Circulationaha.105.567107 |
0.478 |
|
| 2006 |
Shadid S, LaForge R, Otvos JD, Jensen MD. Treatment of obesity with diet/exercise versus pioglitazone has distinct effects on lipoprotein particle size. Atherosclerosis. 188: 370-6. PMID 16313908 DOI: 10.1016/J.Atherosclerosis.2005.10.038 |
0.347 |
|
| 2006 |
Yishak AA, Costacou T, Virella G, Zgibor J, Fried L, Walsh M, Evans RW, Lopes-Virella M, Kagan VE, Otvos J, Orchard TJ. Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 93-100. PMID 16144851 DOI: 10.1093/Ndt/Gfi103 |
0.378 |
|
| 2006 |
Ruaño G, Seip RL, Windemuth A, Zöllner S, Tsongalis GJ, Ordovas J, Otvos J, Bilbie C, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos TJ, Pescatello L, Moyna N, et al. Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis. 185: 65-9. PMID 16005460 DOI: 10.1016/J.Atherosclerosis.2005.05.029 |
0.397 |
|
| 2006 |
Elharchaoui K, Steeg WAVD, Boekholdt SM, Stroes ESG, Otvos JD, Kuivenhoven JA, Bingham SA, Day NE, Khaw KT, Kastelein JJP. Mo-P1:109 LDL particle number and risk for future cardiovascular risk Atherosclerosis Supplements. 7: 70. DOI: 10.1016/S1567-5688(06)80244-8 |
0.377 |
|
| 2005 |
Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation. 111: 3465-72. PMID 15983261 DOI: 10.1161/Circulationaha.104.512079 |
0.41 |
|
| 2005 |
Kwiterovich PO, Cockrill SL, Virgil DG, Garrett ES, Otvos J, Knight-Gibson C, Alaupovic P, Forte T, Zhang L, Farwig ZN, Macfarlane RD. A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age. Jama. 293: 1891-9. PMID 15840864 DOI: 10.1001/Jama.293.15.1891 |
0.404 |
|
| 2005 |
Suter PM, Marmier G, Veya-Linder C, Hänseler E, Lentz J, Vetter W, Otvos J. Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size Atherosclerosis. 180: 127-135. PMID 15823285 DOI: 10.1016/J.Atherosclerosis.2004.11.023 |
0.416 |
|
| 2005 |
Goff DC, D'Agostino RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism: Clinical and Experimental. 54: 264-70. PMID 15690322 DOI: 10.1016/J.Metabol.2004.09.002 |
0.414 |
|
| 2005 |
Ma K, Forte T, Otvos JD, Chan L. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 149-54. PMID 15539616 DOI: 10.1161/01.Atv.0000150414.89591.6A |
0.345 |
|
| 2004 |
Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Current Atherosclerosis Reports. 6: 381-7. PMID 15296705 DOI: 10.1007/S11883-004-0050-5 |
0.512 |
|
| 2004 |
Tsai MY, Georgopoulos A, Otvos JD, Ordovas JM, Hanson NQ, Peacock JM, Arnett DK. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. Clinical Chemistry. 50: 1201-4. PMID 15142979 DOI: 10.1373/Clinchem.2004.032938 |
0.453 |
|
| 2004 |
Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clinical Chemistry. 50: 1189-200. PMID 15107310 DOI: 10.1373/Clinchem.2004.032763 |
0.438 |
|
| 2004 |
Kuivenhoven JA, Hovingh GK, van Tol A, Jauhiainen M, Ehnholm C, Fruchart JC, Brinton EA, Otvos JD, Smelt AH, Brownlee A, Zwinderman AH, Hayden MR, Kastelein JJ. Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size. Atherosclerosis. 171: 311-9. PMID 14644402 DOI: 10.1016/J.Atherosclerosis.2003.08.014 |
0.429 |
|
| 2003 |
Li Z, Otvos JD, Lamon-Fava S, Carrasco WV, Lichtenstein AH, McNamara JR, Ordovas JM, Schaefer EJ. Men and women differ in lipoprotein response to dietary saturated fat and cholesterol restriction. The Journal of Nutrition. 133: 3428-33. PMID 14608054 DOI: 10.1093/Jn/133.11.3428 |
0.399 |
|
| 2003 |
Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney International. 64: 817-28. PMID 12911531 DOI: 10.1046/J.1523-1755.2003.00164.X |
0.472 |
|
| 2003 |
Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 26: 810-8. PMID 12610042 DOI: 10.2337/Diacare.26.3.810 |
0.385 |
|
| 2003 |
Ma K, Cilingiroglu M, Otvos JD, Ballantyne CM, Marian AJ, Chan L. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proceedings of the National Academy of Sciences of the United States of America. 100: 2748-53. PMID 12601178 DOI: 10.1073/Pnas.0438039100 |
0.442 |
|
| 2002 |
Colhoun HM, Taskinen MR, Otvos JD, Van Den Berg P, O'Connor J, Van Tol A. Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes. Diabetes. 51: 3300-5. PMID 12401722 DOI: 10.2337/Diabetes.51.11.3300 |
0.435 |
|
| 2002 |
Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 106: 1930-7. PMID 12370215 DOI: 10.1161/01.Cir.0000033222.75187.B9 |
0.435 |
|
| 2002 |
Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, Siscovick D, Freedman DS, Kronmal R. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1175-80. PMID 12117734 DOI: 10.1161/01.Atv.0000022015.97341.3A |
0.369 |
|
| 2002 |
Brousseau ME, O'Connor JJ, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1148-54. PMID 12117730 DOI: 10.1161/01.Atv.0000024566.57589.2E |
0.457 |
|
| 2002 |
Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. The American Journal of Cardiology. 90: 89-94. PMID 12106834 DOI: 10.1016/S0002-9149(02)02427-X |
0.456 |
|
| 2002 |
Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes. 51: 1949-56. PMID 12031985 DOI: 10.2337/Diabetes.51.6.1949 |
0.428 |
|
| 2002 |
Otvos JD, Shalaurova I, Freedman DS, Rosenson RS. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial. Atherosclerosis. 160: 41-8. PMID 11755921 DOI: 10.1016/S0021-9150(01)00544-5 |
0.496 |
|
| 2001 |
Galluzzi JR, Cupples LA, Otvos JD, Wilson PWF, Schaefer EJ, Ordovas JM. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis. 159: 417-424. PMID 11730822 DOI: 10.1016/S0021-9150(01)00517-2 |
0.35 |
|
| 2001 |
Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PWF, Lahoz C, Cucinotta D, Couture P, Mallory T, Schaefer EJ, Ordovas JM. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis. 158: 173-181. PMID 11500189 DOI: 10.1016/S0021-9150(01)00409-9 |
0.415 |
|
| 2001 |
Tangney CC, Mosca LJ, Otvos JD, Rosenson RS. Oral 17β-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size Atherosclerosis. 155: 425-430. PMID 11254913 DOI: 10.1016/S0021-9150(00)00577-3 |
0.434 |
|
| 2001 |
Freedman DS, Bowman BA, Srinivasan SR, Berenson GS, Otvos JD. Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. Metabolism-Clinical and Experimental. 50: 370-376. PMID 11230794 DOI: 10.1053/Meta.2001.21027 |
0.476 |
|
| 2001 |
Miller M, Dolinar C, Cromwell W, Otvos JD. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia. American Journal of Cardiology. 87: 232-234. PMID 11152850 DOI: 10.1016/S0002-9149(00)01327-8 |
0.423 |
|
| 2000 |
Freedman DS, Bowman BA, Otvos JD, Srinivasan SR, Berenson GS. Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study Atherosclerosis. 152: 441-449. PMID 10998473 DOI: 10.1016/S0021-9150(99)00495-5 |
0.447 |
|
| 2000 |
Isasi CR, Shea S, Deckelbaum RJ, Couch SC, Starc TJ, Otvos JD, Berglund L. Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University biomarkers study Pediatrics. 106: 568-575. PMID 10969104 DOI: 10.1542/Peds.106.3.568 |
0.395 |
|
| 2000 |
Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PWF, Schaefer EJ. Association of Cholesteryl Ester Transfer Protein–TaqIB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk : The Framingham Study Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1323-1329. PMID 10807749 DOI: 10.1161/01.Atv.20.5.1323 |
0.465 |
|
| 2000 |
Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PWF, Schaefer EJ, Ordovas JM. Association of the C−514T Polymorphism in the Hepatic Lipase Gene With Variations in Lipoprotein Subclass Profiles The Framingham Offspring Study Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 815-822. PMID 10712408 DOI: 10.1161/01.Atv.20.3.815 |
0.438 |
|
| 2000 |
Couture P, Otvos JD, Cupples LA, Wilson PWF, Schaefer EJ, Ordovas JM. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis. 148: 337-343. PMID 10657570 DOI: 10.1016/S0021-9150(99)00281-6 |
0.464 |
|
| 2000 |
Rosenson R, Shalaurova I, Otvos J. Relations of lipoprotein subclass levels and LDL size to reduction in coronary atherosclerosis in the PLAC I trial Atherosclerosis. 151: 237. DOI: 10.1016/S0021-9150(00)81073-4 |
0.385 |
|
| 2000 |
Otvos J, Jeyarajah E, Ordovas J, McNamara J, Schaefer E, Wilson P. Lipoprotein subclasses measured by NMR spectroscopy help explain the sex differential in coronary artery disease: Results from the Framingham Offspring Study Atherosclerosis. 151: 128. DOI: 10.1016/S0021-9150(00)80578-X |
0.337 |
|
| 2000 |
Otvos J, Cromwell W, Alexander C, Landsman P, Kush D, Mercuri M. Effects of simvastatin and atorvastatin on total and fractionated HDL cholesterol Atherosclerosis. 151: 48. DOI: 10.1016/S0021-9150(00)80217-8 |
0.432 |
|
| 2000 |
Colhoun HM, Scheek LM, Otvos J, Fuller JH, Tol AV. Cholesteryl ester transfer is associated with HDL size and coronary artery calcification in type 1 diabetic and non-diabetic subjects Atherosclerosis. 151: 14. DOI: 10.1016/S0021-9150(00)80061-1 |
0.321 |
|
| 1999 |
Yu HH, Ginsburg GS, O'Toole ML, Otvos JD, Douglas PS, Rifai N. Acute changes in serum lipids and lipoprotein subclasses in triathletes as assessed by proton nuclear magnetic resonance spectroscopy. Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 1945-9. PMID 10446075 DOI: 10.1161/01.Atv.19.8.1945 |
0.494 |
|
| 1999 |
Otvos J. Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy. Clinical Cardiology. 22. PMID 10376193 DOI: 10.1002/Clc.4960221405 |
0.502 |
|
| 1998 |
Vadlamudi S, MacLean P, Israel RG, Marks RH, Hickey M, Otvos J, Barakat H. Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins. Metabolism: Clinical and Experimental. 47: 1222-6. PMID 9781625 DOI: 10.1016/S0026-0495(98)90327-4 |
0.472 |
|
| 1998 |
Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1046-53. PMID 9672064 DOI: 10.1161/01.Atv.18.7.1046 |
0.515 |
|
| 1998 |
Giri S, Thompson PD, Taxel P, Contois JH, Otvos J, Allen R, Ens G, Wu AH, Waters DD. Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. Atherosclerosis. 137: 359-66. PMID 9622279 DOI: 10.1016/S0021-9150(98)00022-7 |
0.453 |
|
| 1998 |
Giri S, Thompson PD, Contois JH, Taxel P, Otvos J, Allen R, Ens G, Wu AHB, Waters DD. Low-dose estrogen improves serum lipids, homocysteine, and fibrinolysis without altering markers of hemostasis in elderly men Journal of the American College of Cardiology. 31: 194-195. DOI: 10.1016/S0735-1097(98)81485-X |
0.354 |
|
| 1997 |
Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, Brunzell JD, Otvos JD, Sallan SE, Rifai N. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood. 89: 1886-1895. DOI: 10.1182/Blood.V89.6.1886 |
0.413 |
|
| 1992 |
Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clinical Chemistry. 38: 1632-1638. DOI: 10.1093/Clinchem/38.9.1632 |
0.417 |
|
| Show low-probability matches. |